Merck Spin-off (Women’s Health, Generics, Biosimilars) Notes
March 18, 2021 Updates
- Merck just announced that it filed its Form 10 for Organon, the new name for its Women’s Health, Generics, and Biosilimars Business.
- An investor day is scheduled for May 3 ahead of the spin-off which is expected to be completed in late Q2 2021.
- Here is a snapshot of Organon’s income statement per the Form 10:
- Here’s what managent said at the time of the spin-off: